1 / 2000Read later0Read MoreU.S. IPO Weekly Recap: Trickle Of Biotech Activity Continues Amid Tech Sell-OffAll Articles on Seeking Alpha·3 days ago#XuvlBkto#seekingalpha#biotech#week#filings#debuted+4 more🧰Tag tools✨Add tagReading 0:0015s thresholdBookmarkHomeStock IdeasIPO AnalysisSummaryOne biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings.One IPO is currently scheduled for the week ahead as investors continue to hold their breath for the year’s last potential mega IPO.Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring. Vertigo3d/E+ via Getty Images One biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings. Allergy and autoimmune biotech Lycia Therapeutics (LYCA) priced its upsized IPO at the top of the range
HomeStock IdeasIPO AnalysisSummaryOne biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings.One IPO is currently scheduled for the week ahead as investors continue to hold their breath for the year’s last potential mega IPO.Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring. Vertigo3d/E+ via Getty Images One biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings. Allergy and autoimmune biotech Lycia Therapeutics (LYCA) priced its upsized IPO at the top of the range
